Next Article in Journal
Factors Influencing Adherence to Self-Care in Patients with Type 2 Diabetes: A Systematic Literature Review
Previous Article in Journal
Acute Effects of Adding Self-Control Tasks to the Daily Mile on Subsequent Cognition and Enjoyment in Children
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Complexity of Cardiovascular Regulation and Its Association with Physical and Cardiorespiratory Fitness in Men with Type 2 Diabetes Mellitus

by
Étore De F. Signini
1,*,
Raphael M. de Abreu
2,3,
Alex Castro
4,
Andréia M. Santos
1,
Gabriela A. M. Galdino
1,
Silvia C. G. Moura
1,
Stephanie N. Linares
1,
Juliana C. Milan-Mattos
1,
Rafaella M. Zambetta
1,
Alberto Porta
5,6 and
Aparecida M. Catai
1,*
1
Department of Physiotherapy, Universidade Federal de São Carlos, São Carlos 13565-905, Brazil
2
Department of Health, LUNEX University of Applied Sciences, 4671 Differdange, Luxembourg
3
LUNEX ASBL Luxembourg Health & Sport Sciences Research Institute, 4671 Differdange, Luxembourg
4
Brazilian Biosciences National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas 13083-100, Brazil
5
Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy
6
Department of Cardiothoracic, Vascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 San Donato Milanese, Italy
*
Authors to whom correspondence should be addressed.
Healthcare 2026, 14(7), 940; https://doi.org/10.3390/healthcare14070940
Submission received: 28 February 2026 / Revised: 27 March 2026 / Accepted: 1 April 2026 / Published: 3 April 2026
(This article belongs to the Special Issue Effects of Physical Exercise on Cardiometabolic Disorders)

Abstract

Background/Objectives: Cardiovascular regulation complexity (CRC) is an underexplored health marker in the context of type 2 diabetes mellitus (T2DM). Additionally, associating CRC with physical and cardiorespiratory fitness variables could provide greater insight into how physical conditioning impacts cardiovascular health in the context of T2DM. This study aims to investigate whether the relationship between physical and cardiorespiratory fitness and CRC differs according to the presence or absence of T2DM. Methods: Sixty-eight men were equally divided into the T2DM group (T2DMG; 57 ± 6 years old and 28.4 ± 3.1 kg/m2) and the control group (CG; 52 ± 5 years old and 25.1 ± 2.8 kg/m2). Participants underwent a resting cardiovascular data collection and a cardiopulmonary exercise test on a cycle ergometer. For each group, the relative peak power (W/kgPEAK) and peak oxygen consumption (VO2PEAK) were correlated with the CRC indices, namely, Shannon entropy, the complexity index, the normalized complexity index, and the sample entropy from heart period (HP) and systolic arterial pressure (SAP) series. A partial correlation was performed for each group, controlling for age, physical activity level, and metabolic cart. Results: Only the CG showed positive and significant correlations between relative VO2PEAK and W/kgPEAK and CRC indices derived from the HP series (0.354 ≤ r ≤ 0.548 and 0.001 ≤ p ≤ 0.047). Correlations with the SAP series were not significant, regardless of the groups. Conclusions: In this sample, there was no positive relationship between physical and cardiorespiratory fitness variables and CRC indices among individuals with T2DM. Further large sample studies are needed to elucidate the factors involved in T2DM that impact CRC.

1. Introduction

Type 2 diabetes mellitus (T2DM) is an emerging health problem due to its increasing number of cases over the years [1]. The increased prevalence of this condition is often related to unhealthy lifestyle habits (such as sedentary behavior and imbalanced diet) resulting from environmental and social changes inherent in society’s development, population aging, and the lack of support policies in sectors such as health, agriculture, transportation, food processing, and education [2,3,4]. Additionally, T2DM involves impaired insulin production, chronic hyperglycemia, and often plays a role in the genesis and progression of potentially fatal or nonfatal debilitating cardiovascular diseases [5,6,7].
Cardiovascular and metabolic diseases are typically linked to impaired regulatory mechanisms [8,9]. The cardiovascular system plays an important role in the body, focusing especially on supplying vital functions and aiding in the elimination of waste products [10]. It is composed of highly specialized and complex subsystems that interact with each other and central neural commands to accomplish tasks [10]. This interaction aims to regulate the cardiovascular system to maintain homeostasis and meet the body’s energy demands [11,12]. Cardiovascular regulation is an incessant process, and its complexity is directly related to the integrity of the subsystems and the quality of interactions between them [10]. Therefore, cardiovascular regulation complexity (CRC) serves as an indicator of cardiovascular health, which may decrease in pathological conditions [10]. This makes the study of the connection between T2DM and CRC promising, since it might show how T2DM affects the complexity of autonomic regulations and their interaction above and beyond the well-known impact of T2DM on autonomic function.
Previous studies by our group have shown that T2DM alone does not significantly alter some indices of CRC under resting conditions [13]. However, little is known about the influence of T2DM on CRC in the context of physical fitness. The T2DM impairs cardiorespiratory fitness (CRF) and physical fitness primarily through the induction of changes of myocardiogenic, myogenic, vasogenic, and neurogenic origin [14,15]. Nevertheless, regular physical exercise improves physical fitness, reduces the negative effects of T2DM, improves health conditions, and enhances the functionality of patients affected by this clinical condition [16]. Although this is well-established, the relationship between fitness level and CRC in the context of T2DM remains largely unknown.
A greater level of physical fitness is expected to result from greater systemic integrity and, therefore, may be associated with greater CRC. This speculation becomes intriguing in the context of T2DM since cardiometabolic impairment is already involved. Therefore, it is important to evaluate the relationship between CRC and physical fitness in the context of T2DM. The results of this study may contribute to a better understanding of how physical conditioning affects the cardiovascular health of individuals with T2DM. Thus, this study aimed to investigate whether the relationship between physical and cardiorespiratory fitness and CRC differs according to the presence or absence of T2DM.

2. Materials and Methods

2.1. Subjects

A total of 68 men, aged 45 to 70 years, were evaluated. The participants were divided equally into two groups: individuals who were apparently healthy (control group (CG)) and individuals with T2DM (type 2 diabetes mellitus group (T2DMG)), as classified by the American Diabetes Association [17]. The T2DMG included individuals without diagnosed inflammatory, cerebrovascular, cardiovascular, or respiratory disease not directly related to T2DM, and without mobility limitations. Additionally, they were not regular alcohol consumers, had been smoke-free for at least one year, and did not use medications (such as beta-blockers) that directly act in cardiovascular autonomic modulation. The CG consisted of individuals with the same characteristics, but without T2DM. Individuals with significant cardiovascular abnormalities observed during the protocol, such as signs of myocardial ischemia (ST segment depression), excessive arrhythmias, blood pressure hyperreactivity, or recurrent hypotension, were excluded, as well as individuals with blood test results suggesting other significant diseases (such as leukemia).
This study was approved by the Human Research Ethics Committee at the Federal University of São Carlos (UFSCar) (numbers: 6.848.846 and 3.852.163) and conducted in accordance with the standards set by the Declaration of Helsinki. All participants signed a free and informed consent form after agreeing to participate in this study.

2.2. Experimental Design

After agreeing to participate in this study, the participants underwent tests and assessments. These were divided into two days with a short interval between them (≤14 days). On the first day, the participants had their resting cardiovascular data collected. On the second day, they performed the cardiopulmonary exercise test (CPET). The participants also underwent a fasting blood test at a specialized laboratory in São Carlos. The test was performed after 10 to 12 h of fasting to assess their health condition.
For all tests and assessments, individuals were instructed to avoid strenuous physical activity on the day before and on the day of the assessments. They were also instructed to abstain from consuming food and beverages containing alcohol or stimulants (e.g., coffee, energy drinks, and foods with high amounts of added sugar) for 24 h before the tests and assessments. Additionally, they were advised to get a proper night’s rest the night before and not arrive fasting (excluding for blood tests) or immediately after a meal. Participants received text messages or phone reminders about these instructions in the days before the assessments and were asked about their adherence to the instructions on assessment days. The two days of evaluation performed at the cardiovascular physiotherapy laboratory (LFCV) of UFSCar were conducted in rooms with controlled environmental conditions. The environmental temperature was maintained between 21 °C and 24 °C, and the relative humidity was kept between 40% and 60% [18].

2.3. Cardiovascular Data Collection

After stabilizing the cardiovascular variables in the supine position for 10 min, the electrocardiogram (ECG) and continuous noninvasive blood pressure were collected continuously for 15 min at rest. During this time, participants were instructed to remain still, silent, and awake.
The ECG signals were acquired via MC5 lead (BioAmp FE132, ADInstruments, Bella Vista, NSW, Australia), and the arterial pressure was acquired using non-invasive finger photophethysmography (Finometer Pro, Finapres Medical Systems, Enschede, The Netherlands). Analog-to-digital conversion was carried out by the acquisition device Power Laboratory 8/35 hardware (ADInstruments, Bella Vista, NSW, Australia) and analyzed with the LabChart software, version 7.3.8 (ADInstruments, Dunedin, New Zealand).

2.4. Cardiopulmonary Exercise Test (CPET)

The CPET was performed on a cycle ergometer (CORIVAL V3, Lode BV, Groningen, The Netherlands) using a ramp protocol. The increment calculation was based on the Wasserman equation [19] with adaptations, according to the evaluator’s experience [20], for more physically active individuals. The CPET consisted of a 3 min warm-up with no added load, followed by 8 to 12 min of ramp increment and 6 min of active recovery. If the load increase was either overestimated or underestimated, leading to a ramp increment time of less than 8 min or more than 12 min, respectively, the evaluation was rescheduled for another day. The revolutions per minute were kept between 60 and 70 during warm-up, increment, and active recovery. The test was conducted until exhaustion or the occurrence of a termination criterion, according to Balady’s proposal [21]. The peak oxygen consumption (VO2PEAK) was calculated using the average of the last 30 s, and the peak power (WPEAK) was the highest value achieved during the load increment phase. In this study, the variables of greatest interest obtained in the CPET were the relative VO2PEAK and WPEAK, expressed as VO2PEAK (mL/kg/min) and W/kgPEAK, respectively, as these variables provide precise information about CRF and physical fitness. All patients undergoing CPET were attended to by a cardiologist.
Ventilatory and metabolic variables were obtained, breath-by-breath, through a metabolic cart (ULTIMA MedGraphics, St. Paul, MN, USA) and processed using specific software (Breeze Suite 7.1, MedGraphics, St. Paul, MN, USA). The 12-lead ECG was obtained by an electrocardiograph (CardioPerfect, Welch Allyn, New York, NY, USA). A metabolic cart VMAX (Encore, Carefusion, Yorba Linda, CA, USA) and the 12-lead ECG obtained by WinCardio System (WinCardio® System, Micromed, Brasília, Brazil) were also used.

2.5. CRC

To perform the CRC analysis, sequences of 256 consecutive heart period (HP) and systolic arterial pressure (SAP) values were selected from the most stable regions of the tachogram and systogram [18,22,23], respectively, as defined by visual inspection [18]. The HP and SAP values were carefully checked to avoid erroneous detections or missed beats due to alterations in R-wave and blood pressure delineations before sequence selection [18]. Isolated ectopic beats were corrected using linear interpolation with unaffected adjacent HP and SAP values [24]. We opted to evaluate CRC using indices derived from the HP and SAP series to assess the cardiac control complexity through the analysis of the HP series and vascular control complexity through the analysis of the SAP series. The following complexity indices were computed: Shannon’s entropy (SE) [25], the complexity index (CI) [26,27], the normalized complexity index (NCI) [26,27], and sample entropy (SampEn) [28].
SE was conducted in accordance with previous studies by our group [25,27]. Detailed descriptions of the methodology can be found in Porta et al. (2001) [25]. Briefly, stable sequences with HP and SAP values were uniformly quantized over six levels. The original values were replaced by symbols encoding quantization levels from 0 to 5. Then, patterns composed of three consecutive symbols were created. The shape of the distribution of the patterns generated was described by SE [25]. When the distribution is flat, SE is large as all the patterns are equally present and the complexity of the series is high. Meanwhile, when there is a subset of patterns that are most likely associated with the absence or uncommon occurrence of other patterns, SE is small as well as the complexity [25].
The CI and NCI indices are associated with the corrected conditional entropy (CCE) introduced by Porta et al. (1998) [26], grounded on an estimate of conditional entropy (CE). Briefly, the CE measures the amount of information in a new sample that cannot be determined from a sequence of L previous values. The CE computation is biased when computed over a short segment of data, and its calculation was made more robust via the CCE [26]. It has been shown that, as a function of L, the CCE remains constant for white noise, decreases to zero for totally predictable signals, and shows a minimum when repetitive patterns are immersed in noise [27]. The approximation of probabilities through sampling frequencies was performed using the same uniform quantization utilized in the SE analysis. The pattern length L was not a priori fixed, but it was optimized by selecting the value of L minimizing CCE. The CCE minimum was defined as the CI. The NCI was computed by dividing the CI by SE, and, therefore, expresses complexity in terms of dimensionless units [26,27]. Both indices increase with complexity and decrease with regularity.
Finally, the SampEn index was introduced by Richman and Moorman in 2000 [28]. It was calculated using m = 2 and r = 0.2·SD. This index monitors how close together a set of patterns is for a few observations [28]. Reduced SampEn values are indicative of greater regularity and predictability.

2.6. Statistical Analysis

Initially, given the presence of some individuals with cardiovascular autonomic neuropathy (CAN) in the T2DMG and recognizing the effect of CAN on cardiovascular autonomic modulation, a principal component analysis (PCA) with a Permutational Analysis of Multivariate Variance (PERMANOVA) was performed for T2DMG, including all used variables/indices from the CPET and CRC, to assess the effect of CAN on the results. The presence of CAN was determined through the application of cardiovascular autonomic tests, which were described in detail in previous studies by our group [29]. For the same reason as CAN, the effects of antihypertensive medications were also evaluated using PCA for T2DMG.
Normality was assessed using the Shapiro–Wilk test, and the homogeneity of the data was assessed using the Levene test. Data that did not meet the assumptions were transformed using Box–Cox transformations. Then, a one-way ANOVA was performed to compare the groups (T2DMG and CG), controlling for “age”, “physical activity level” (taking into account the criterion of 150 min of physical activity per week) [30], “metabolic cart”, and “body mass index (BMI)”. This analysis considered all indices and variables from the CPET and CRC. Categorical data were compared using the chi-square test, and the data on the subjects’ characteristics (e.g., blood tests) were evaluated using a t-test.
A partial correlation was performed among the VO2PEAK and W/kgPEAK variables and the indices obtained in the CRC analysis for each group (T2DM and CG). This correlation used the “age”, “physical activity level”, and the “metabolic cart” as control variables.
All statistical tests applied a significant threshold of p < 0.05. Except for PCA, analyses were performed using the SPSS software, version 25.0. The PCA was performed using the MetaboAnalyst 6.0 software (https://www.metaboanalyst.ca/).

3. Results

3.1. Participant Characteristics

Initially, a total of 146 individuals were invited to participate in the initial evaluation (anamnesis). However, 33 individuals did not meet the inclusion criteria, and 45 individuals were excluded from this study during the experimental protocol due to significant changes in blood test results (n = 26), dropping out of this study (n = 8), significant changes in blood pressure during data collection (n = 6), and excessive arrhythmias (n = 5). Thus, the data of 68 individuals (34 with T2DM) were analyzed.
Table 1 shows the characteristics of the groups. The T2DMG group was older and had higher values for weight, BMI, leukocytes, glycated hemoglobin (HbA1c), basal insulin, fasting glucose, Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), high-sensitivity C-reactive protein (hs-CRP), very-low-density lipoprotein (VLDL)-cholesterol, and triglycerides. The CG group had higher values for erythrocytes, high-density lipoprotein (HDL)-cholesterol, and low-density lipoprotein (LDL)-cholesterol, although all values were within the normal range or borderline [31]. It is also noteworthy that the T2DMG had more inactive individuals than the CG, and nearly half of its participants had CAN and used antihypertensive medication.

3.2. Influence of CAN and Antihypertensive Agents

The PCA showed no influence of CAN on the analyzed data (Figures S1 and S3). This indicated that CAN did not significantly affect the CRC indices and CPET variables’ profiles. Regarding antihypertensive medications, they proved to be slightly more relevant in the PCA analysis (Figures S2 and S3) since antihypertensive agents, unlike CAN, were significant (through the results of PERMANOVA) in comparisons that included principal component 2 (which represents only 23.7% of the total variability of the data). Thus, their effects were previously verified in the partial correlations. However, antihypertensives were particularly related to BMI and, consequently, to W/kgPEAK and VO2PEAK (in mL/kg/min) (Table S1). This information suggests that the association of this type of medication with the data was mainly due to their relationship with BMI. Therefore, adjusting the correlation for antihypertensives could generate artificial data that might not be associated with physiological events. Therefore, antihypertensives were not included as a control variable in the partial correlation analysis, even though they might have a small influence on the results in the SAP series.

3.3. Comparison Between Groups

There were no significant differences between the CG and T2DMG in terms of complexity indices (Table 2) after adjusting for BMI, age, metabolic cart, and physical activity level. However, significant differences were observed between the groups for CRF (VO2PEAK) and physical fitness (WPEAK and W/kgPEAK) variables (Table 2), with higher values in the CG.

3.4. Relationship Between CRC and Physical Fitness/CRF

After controlling age, physical activity level, and metabolic cart, a significant inverse relationship was only found between SampEnHP and the W/kgPEAK (r = −0.390; p = 0.027) and VO2PEAK (r = −0.395; p = 0.028) indices in the T2DMG (Figure 1A). In the CG, only direct proportional relationships were observed between fitness variables and CRC indices: SEHP (W/kgPEAK: r = 0.507, p = 0.003; VO2PEAK: r = 0.459, p = 0.008), NCIHP (W/kgPEAK: r = 0.485, p = 0.005; VO2PEAK: r = 0.548, p = 0.001), CIHP (W/kgPEAK: r = 0.523, p = 0.002; VO2PEAK: r = 0.498, p = 0.004), and SampEnHP (VO2PEAK: r = 0.354, p = 0.047) (Figure 1B). However, no significant SAP series complexity index was observed in both groups. Figure 2 presents all correlation coefficients.

4. Discussion

This study investigated the relationship between physical and cardiorespiratory fitness and CRC, considering individuals with T2DM and apparently healthy individuals. As previously observed by our group [13], there were no significant differences in CRC indices values between the evaluated groups, although CRF and physical fitness data were different as expected [32]. The most interesting result, however, was the positive relationship between the complexity indices of the HP variability series and W/kgPEAK and VO2PEAK observed only in apparently healthy individuals.
Despite similar CRC values between individuals with and without T2DM, the relationship between CRC and physical fitness and CRF differed significantly between the groups. This result is counterintuitive because individuals with T2DM should theoretically have a more compromised CRC than healthy individuals, and high physical and cardiorespiratory fitness should independently and positively influence CRC since they are related to health [33,34]. In this context, two plausible explanations may be considered. First, individuals included in T2DM did not present other major diagnosed health complications, such as cardiomyopathy, coronary artery disease, respiratory diseases, or advanced stages of CAN. This could partially explain the similarity between the groups in the present study when CRC indices were compared. Secondly, it has been observed that T2DM may be associated with changes in cardiovascular autonomic modulation without a clear alteration in CRC indices values.
The existing literature provides a small body of research specifically evaluating the association between CRC and diabetes mellitus. Specifically, regarding HP series analysis, the results remain inconclusive and do not provide definitive evidence concerning whether, or how, diabetes mellitus may impact CRC indices values. Some studies indicate a decrease, while others report no significant change [13,35,36,37]. However, it is well-established that T2DM affects cardiac autonomic modulation, as well as the activity and function of the sinoatrial node (SAN) [38,39]. Although a reduction in HP variability due to an impairment in cardiac autonomic modulation is observed in T2DM [29,39], which could result in lower CRC indices values, non-autonomic factors affecting cardiac rhythm must also be considered when analyzing CRC [10,39]. T2DM is linked with a pro-arrhythmogenic metabolic environment [40,41], which, in turn, also leads to alterations in the SAN that compromise intercellular electrical conduction and impact SAN automaticity [38,39]. This overall context implies instabilities within the parasympathetic–SAN–atrial network [38,39,42]. Based on this information, we speculate that the combination of these factors could influence cardiac regulation complexity in individuals with T2DM by increasing the unpredictability of the HP signal unrelated to cardiovascular integrity or parasympathetic autonomic modulation. This could lead to the false impression that CRC is preserved. Accordingly, recent observations indicate that individuals with T2DM exhibit greater heart rate fragmentation (HRF) compared with healthy controls [29]. An elevation in HRF may result in greater HP variability, which could potentially mask the true status related to cardiac autonomic modulation and CRC [42,43]. Considering all these factors, the associations between CRC indices and measures of physical and cardiorespiratory fitness may be changed or abolished. Therefore, CRC does not seem to be positively related to physical and cardiorespiratory fitness in individuals with T2DM who are free of other relevant health complications.
The complexity of the SAP series did not show any significant relationship for either the T2DMG or CG groups. Porta et al. (2012) [24] highlighted that the complexity of the SAP series is lower when compared with the complexity of the HP series. This is attributed to the fact that the HP series is under the influence of autonomic modulation by both branches (sympathetic and parasympathetic), while the SAP series is under the influence of only sympathetic autonomic modulation [24]. Furthermore, a higher sympathetic modulation of the vessels tends to reduce the complexity of the SAP series [24]. In this sense, the absence of significant relationships with physical and cardiorespiratory fitness variables may be attributed, at least in part, to these factors. Therefore, it is not surprising to find out that markers more related to vagal control, such as physical and cardiorespiratory fitness, are more linked to an index such as the CRC of the HP series, more sensitive to vagal withdrawal [24]. However, despite the lack of significance, Figure 2 shows that the CG had solely positive coefficients, whereas the T2DMG had positive and negative coefficients close to zero. This may indicate a trend of a positive association between the complexity of the SAP series and physical and cardiorespiratory fitness in CG, which was not observed in T2DMG. However, it is important to note that some participants in T2DMG were taking antihypertensive medications, which could have slightly influenced these results.
This study provides important information that should be considered when assessing and treating patients with T2DM. Several complexity indices were employed, each derived from distinct calculation methods, thereby providing complementary insights. The SE specifically assesses the distribution of patterns and provides information on the presence or absence of frequent patterns [25]; SampEn assesses the temporal regularity of patterns [28]; and the CI and NCI evaluate the amount of information carried by future values of HP, or SAP, when past data are known [26,27]. Thus, this study conducted a robust analysis of the complexity of HP and SAP series among apparently healthy individuals and those with T2DM. In summary, CRC is not positively related to physical and cardiorespiratory fitness in individuals with T2DM without major health complications, unlike healthy individuals. Although negative correlations were observed between fitness variables and SampEn in the T2DMG, these findings were isolated and among the least significant, which limits reliable inferences. However, the potentially significant influence of non-autonomic factors on CRC in individuals with T2DM should be considered. Finally, the complexity of the SAP series appears to be of little relevance to the association with markers of physical and cardiorespiratory fitness.
This study had some limitations. First, the groups were not similar in terms of age, BMI, or physical activity level. Although these factors were all considered in the statistical analysis, we cannot exclude the possibility that these group differences had a residual influence on the results. Second, two metabolic carts were used. This fact, although controlled by statistical analysis, may have minimally influenced the results. Third, the evaluation was performed on only one sex. Women were not included in this study due to the impact of the menstrual cycle on CRC analyses. It would have been necessary to adjust the evaluations on specific days, and considering our limited resources, collecting data from both sexes was not feasible. In this context, it is important to note that the results of this study are limited to men. Nevertheless, this study employed rigorous criteria for cardiovascular data collection and data analysis, providing valuable new insights into the relationship between CRC and physical and cardiorespiratory fitness variables in the context of T2DM.

5. Conclusions

The CRC of the HP series was positively associated with markers of physical and cardiorespiratory fitness in apparently healthy men. However, this relationship was not observed in individuals with T2DM without other serious health complications. In addition, the relationships from the SAP series were insignificant for both CG and T2DMG. These results indicate that further large sample studies are needed to elucidate the factors involved in T2DM that impact CRC. Finally, the relationship evaluated in this study also needs to be elucidated for women.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/healthcare14070940/s1, Table S1: Partial correlations considering individuals with T2DM. Figure S1. Principal components analysis for CAN. Figure S2. Principal components analysis for antihypertensive agents. Figure S3. Scree plot.

Author Contributions

Conceptualization, É.D.F.S., R.M.d.A. and A.C.; Methodology, É.D.F.S., R.M.d.A., A.C., A.M.C., A.P., A.M.S., G.A.M.G., S.C.G.M., S.N.L. and J.C.M.-M.; Software, A.P.; Formal Analysis, É.D.F.S., A.C., R.M.d.A., A.M.S., G.A.M.G., S.C.G.M., S.N.L., J.C.M.-M. and R.M.Z.; Investigation, É.D.F.S., R.M.d.A., A.C., A.M.S., G.A.M.G., S.C.G.M., S.N.L., J.C.M.-M. and R.M.Z.; Resources, A.M.C.; Data Curation, É.D.F.S., A.C., R.M.d.A., A.M.S., G.A.M.G., S.C.G.M., S.N.L., J.C.M.-M. and R.M.Z.; Writing—Original Draft Preparation, É.D.F.S., R.M.d.A., A.C. and R.M.Z.; Writing—Review and Editing, É.D.F.S., R.M.d.A., A.C., A.M.C., A.M.S., G.A.M.G., S.C.G.M., S.N.L., J.C.M.-M., R.M.Z. and A.P.; Visualization, É.D.F.S.; Project Administration, A.M.C., É.D.F.S., R.M.d.A. and A.C.; Funding Acquisition, A.M.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the São Paulo Research Foundation (FAPESP), grant numbers: #2023/09582-4, #2023/01626-2, #2018/25082-3, and #2016/22215-7; the National Council for Scientific and Technological Development (CNPq), grant numbers: #151218/2023-4 and #425360/2018; and the Coordination for the Improvement of Higher Education (CAPES), grant number: 001.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Ethics Committee of Human Research Ethics Committee at UFSCar, protocol code numbers: 6.848.846 (approved on 24 May 2024) and 3.852.163 (approved on 20 February 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

The original contributions presented in this study are included in this article/Supplementary Material. Further inquiries can be directed to the corresponding authors.

Acknowledgments

We are grateful to all participants involved in this study and extend our thanks to the laboratory staff for their technical support. We also acknowledge the financial support provided by the funding agencies.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BMIBody mass index
CANCardiovascular autonomic neuropathy
CEConditional entropy
CCECorrected CE
CGControl group
CIComplexity index
CPETCardiopulmonary exercise test
CRCCardiovascular regulation complexity
CRFCardiorespiratory fitness
ECGElectrocardiogram
HbA1cGlycated hemoglobin
HDLHigh-density lipoprotein
HOMA-IRHomeostasis Model Assessment of Insulin Resistance
HPHeart period
HRFHeart rate fragmentation
hs-CRPHigh-sensitivity C-reactive protein
LDLLow-density lipoprotein
NCINormalized complexity index
PCAPrincipal component analysis
SampEnSample entropy
SAPSystolic arterial pressure
SEShannon’s entropy
T2DMType 2 diabetes mellitus
T2DMGType 2 diabetes mellitus group
VLDLVery-low-density lipoprotein
VO2PEAKPeak oxygen consumption
VO2/HROxygen pulse
WPEAKPeak power
W/kgPEAKRelative Watts at peak of exercise

References

  1. International Diabetes Federation. IDF Diabetes Atlas, 10th ed.; International Diabetes Federation: Brussels, Belgium, 2023. [Google Scholar]
  2. Lee, A.; Cardel, M.; Donahoo, W.T. Social and Environmental Factors Influencing Obesity. In Endotext; Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., Hofland, J., et al., Eds.; MDText.com, Inc.: South Dartmouth, MA, USA, 2000. [Google Scholar]
  3. Samant, A.C.; Jha, H.; Kamal, P. Systematic Review: Risk Factors for Developing Type 2 Diabetes Mellitus. Eur. J. Cardiovasc. Med. 2025, 15, 382–390. [Google Scholar]
  4. Khan, M.A.B.; Hashim, M.J.; King, J.K.; Govender, R.D.; Mustafa, H.; Al Kaabi, J. Epidemiology of Type 2 Diabetes—Global Burden of Disease and Forecasted Trends. J. Epidemiol. Glob. Health 2020, 10, 107–111. [Google Scholar] [CrossRef]
  5. Giraldo-Gonzalez, G.C.; Roman-Gonzalez, A.; Cañas, F.; Garcia, A. Molecular Mechanisms of Type 2 Diabetes-Related Heart Disease and Therapeutic Insights. Int. J. Mol. Sci. 2025, 26, 4548. [Google Scholar] [CrossRef]
  6. Leon, B.M.; Maddox, T.M. Diabetes and Cardiovascular Disease: Epidemiology, Biological Mechanisms, Treatment Recommendations and Future Research. World J. Diabetes 2015, 6, 1246–1258. [Google Scholar] [CrossRef] [PubMed]
  7. Mosenzon, O.; Cheng, A.Y.; Rabinstein, A.A.; Sacco, S. Diabetes and Stroke: What Are the Connections? J. Stroke 2023, 25, 26–38. [Google Scholar] [CrossRef] [PubMed]
  8. Carnevale, D. Neuroimmune Axis of Cardiovascular Control: Mechanisms and Therapeutic Implications. Nat. Rev. Cardiol. 2022, 19, 379–394. [Google Scholar] [CrossRef] [PubMed]
  9. Mannozzi, J.; Massoud, L.; Stavres, J.; Al-Hassan, M.-H.; O’Leary, D.S. Altered Autonomic Function in Metabolic Syndrome: Interactive Effects of Multiple Components. J. Clin. Med. 2024, 13, 895. [Google Scholar] [CrossRef]
  10. Porta, A.; Di Rienzo, M.; Wessel, N.; Kurths, J. Addressing the Complexity of Cardiovascular Regulation. Philos. Trans. A Math. Phys. Eng. Sci. 2009, 367, 1215–1218. [Google Scholar] [CrossRef]
  11. Hall, J.E.; Guyton, A.C. Guyton and Hall Textbook of Medical Physiology, 12th ed.; Saunders Elsevier: Philadelphia, PA, USA, 2011. [Google Scholar]
  12. Joyner, M.J.; Casey, D.P. Regulation of Increased Blood Flow (Hyperemia) to Muscles during Exercise: A Hierarchy of Competing Physiological Needs. Physiol. Rev. 2015, 95, 549–601. [Google Scholar] [CrossRef]
  13. Moura-Tonello, S.C.; Takahashi, A.C.; Francisco, C.O.; Lopes, S.L.; Del Vale, A.M.; Borghi-Silva, A.; Leal, A.M.; Montano, N.; Porta, A.; Catai, A.M. Influence of Type 2 Diabetes on Symbolic Analysis and Complexity of Heart Rate Variability in Men. Diabetol. Metab. Syndr. 2014, 6, 13. [Google Scholar] [CrossRef]
  14. Poitras, V.J.; Hudson, R.W.; Tschakovsky, M.E. Exercise Intolerance in Type 2 Diabetes: Is There a Cardiovascular Contribution? J. Appl. Physiol. 2018, 124, 1117–1139. [Google Scholar] [CrossRef] [PubMed]
  15. Nesti, L.; Pugliese, N.R.; Sciuto, P.; Natali, A. Type 2 Diabetes and Reduced Exercise Tolerance: A Review of the Literature through an Integrated Physiology Approach. Cardiovasc. Diabetol. 2020, 19, 134. [Google Scholar] [CrossRef]
  16. Colberg, S.R.; Sigal, R.J.; Yardley, J.E.; Riddell, M.C.; Dunstan, D.W.; Dempsey, P.C.; Horton, E.S.; Castorino, K.; Tate, D.F. Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016, 39, 2065–2079. [Google Scholar] [CrossRef]
  17. American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes—2022. Diabetes Care 2022, 45, S3. [Google Scholar] [CrossRef]
  18. Catai, A.M.; Pastre, C.M.; de Godoy, M.F.; da Silva, E.; de Medeiros Takahashi, A.C.; Vanderlei, L.C.M. Heart Rate Variability: Are You Using It Properly? Standardisation Checklist of Procedures. Braz. J. Phys. Ther. 2020, 24, 91–102. [Google Scholar] [CrossRef]
  19. Wasserman, K. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications; LWW medical book collection; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2005. [Google Scholar]
  20. Costa, D.C.; de Santi, G.L.; Crescêncio, J.C.; Seabra, L.P.; Carvalho, E.E.V.; Papa, V.; Marques, F.; Gallo, L.; Schmidt, A. Use of the Wasserman Equation in Optimization of the Duration of the Power Ramp in a Cardiopulmonary Exercise Test: A Study of Brazilian Men. Braz. J. Med. Biol. Res. 2015, 48, 1136–1144. [Google Scholar] [CrossRef]
  21. Balady, G.J.; Arena, R.; Sietsema, K.; Myers, J.; Coke, L.; Fletcher, G.F.; Forman, D.; Franklin, B.; Guazzi, M.; Gulati, M.; et al. Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement from the American Heart Association. Circulation 2010, 122, 191–225. [Google Scholar] [CrossRef]
  22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Task Force Heart Rate Variability: Standards of Measurement, Physiological Interpretation and Clinical Use. Circulation 1996, 93, 1043–1065. [Google Scholar] [CrossRef]
  23. Lombardi, F.; Huikuri, H.; Schmidt, G.; Malik, M. e-Rhythm Study Group of European Heart Rhythm Association. Short-Term Heart Rate Variability: Easy to Measure, Difficult to Interpret. Heart Rhythm 2018, 15, 1559–1560. [Google Scholar] [CrossRef] [PubMed]
  24. Porta, A.; Castiglioni, P.; Rienzo, M.D.; Bari, V.; Bassani, T.; Marchi, A.; Takahashi, A.C.M.; Tobaldini, E.; Montano, N.; Catai, A.M.; et al. Short-Term Complexity Indexes of Heart Period and Systolic Arterial Pressure Variabilities Provide Complementary Information. J. Appl. Physiol. 2012, 113, 1810–1820. [Google Scholar] [CrossRef] [PubMed]
  25. Porta, A.; Guzzetti, S.; Montano, N.; Furlan, R.; Pagani, M.; Malliani, A.; Cerutti, S. Entropy, Entropy Rate, and Pattern Classification as Tools to Typify Complexity in Short Heart Period Variability Series. IEEE Trans. Biomed. Eng. 2001, 48, 1282–1291. [Google Scholar] [CrossRef]
  26. Porta, A.; Baselli, G.; Liberati, D.; Montano, N.; Cogliati, C.; Gnecchi-Ruscone, T.; Malliani, A.; Cerutti, S. Measuring Regularity by Means of a Corrected Conditional Entropy in Sympathetic Outflow. Biol. Cybern. 1998, 78, 71–78. [Google Scholar] [CrossRef]
  27. Takahashi, A.C.M.; Porta, A.; Melo, R.C.; Quitério, R.J.; da Silva, E.; Borghi-Silva, A.; Tobaldini, E.; Montano, N.; Catai, A.M. Aging Reduces Complexity of Heart Rate Variability Assessed by Conditional Entropy and Symbolic Analysis. Intern. Emerg. Med. 2012, 7, 229–235. [Google Scholar] [CrossRef]
  28. Richman, J.S.; Moorman, J.R. Physiological Time-Series Analysis Using Approximate Entropy and Sample Entropy. Am. J. Physiol. Heart Circ. Physiol. 2000, 278, H2039–H2049. [Google Scholar] [CrossRef]
  29. Galdino, G.A.M.; Eduardo Virgilio Silva, L.; Cristina Garcia Moura-Tonello, S.; Cristina Milan-Mattos, J.; Nogueira Linares, S.; Porta, A.; da Silva, T.M.; Fazan, R.; Beltrame, T.; Maria Catai, A. Heart Rate Fragmentation Is Impaired in Type 2 Diabetes Mellitus Patients. Diabetes Res. Clin. Pract. 2023, 196, 110223. [Google Scholar] [CrossRef]
  30. Garber, C.E.; Blissmer, B.; Deschenes, M.R.; Franklin, B.A.; Lamonte, M.J.; Lee, I.-M.; Nieman, D.C.; Swain, D.P. Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults: Guidance for Prescribing Exercise. Med. Sci. Sports Exerc. 2011, 43, 1334. [Google Scholar] [CrossRef]
  31. Faludi, A.; Izar, M.; Saraiva, J.; Chacra, A.; Bianco, H.; Afiune Neto, A.; Bertolami, A.; Pereira, A.; Lottenberg, A.; Sposito, A.; et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose—2017. Arq. Bras. Cardiol. 2017, 109, 1–76. [Google Scholar] [CrossRef] [PubMed]
  32. de Macedo, A.C.P.; Schaan, C.W.; Bock, P.M.; de Pinto, M.B.; Botton, C.E.; Umpierre, D.; Schaan, B.D. Cardiorespiratory Fitness in Individuals with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Arch. Endocrinol. Metab. 2023, 67, e230040. [Google Scholar] [CrossRef] [PubMed]
  33. Hernández-López, O.A.; Murillo-Ortíz, B.; Luna-Marco, C.; Cacace, J.; Hermo-Argibay, A.; Ramírez, V.; Guevara-Cruz, M.; Pelechá-Salvador, M.; Rocha, M.; Rovira-Llopis, S.; et al. Cardiorespiratory Fitness as a Key Predictor of Metabolic, Inflammatory, and Oxidative Stress Biomarkers in Adults with Different Physical Activity Levels. Free Radic. Biol. Med. 2025, 240, 735–744. [Google Scholar] [CrossRef] [PubMed]
  34. Araújo, C.G.S.; Kunutsor, S.K.; Eijsvogels, T.M.H.; Myers, J.; Laukkanen, J.A.; Hamar, D.; Niebauer, J.; Bhattacharjee, A.; de Souza e Silva, C.G.; Franca, J.F.; et al. Muscle Power Versus Strength as a Predictor of Mortality in Middle-Aged and Older Men and Women. Mayo Clin. Proc. 2025, 100, 1319–1331. [Google Scholar] [CrossRef]
  35. Tarvainen, M.P.; Cornforth, D.J.; Kuoppa, P.; Lipponen, J.A.; Jelinek, H.F. Complexity of Heart Rate Variability in Type 2 Diabetes—Effect of Hyperglycemia. In Proceedings of the 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Osaka, Japan, 3–7 July 2013; pp. 5558–5561. [Google Scholar] [CrossRef]
  36. Tarvainen, M.P.; Laitinen, T.P.; Lipponen, J.A.; Cornforth, D.J.; Jelinek, H.F. Cardiac Autonomic Dysfunction in Type 2 Diabetes—Effect of Hyperglycemia and Disease Duration. Front. Endocrinol. 2014, 5, 130. [Google Scholar] [CrossRef]
  37. Javorka, M.; Trunkvalterova, Z.; Tonhajzerova, I.; Javorkova, J.; Javorka, K.; Baumert, M. Short-Term Heart Rate Complexity Is Reduced in Patients with Type 1 Diabetes Mellitus. Clin. Neurophysiol. 2008, 119, 1071–1081. [Google Scholar] [CrossRef]
  38. Bertrand, A.; Tomek, J.; Rodriguez, B. Cardiac Remodelling in Type 2 Diabetes: Pathophysiological Mechanisms and Opportunities for Multiscale Computational Modelling and Simulation. J. Physiol. 2026. [Google Scholar] [CrossRef]
  39. Al Kury, L.T.; Chacar, S.; Alefishat, E.; Khraibi, A.A.; Nader, M. Structural and Electrical Remodeling of the Sinoatrial Node in Diabetes: New Dimensions and Perspectives. Front. Endocrinol. 2022, 13, 946313. [Google Scholar] [CrossRef] [PubMed]
  40. Hu, T.; Zhang, W.; Han, F.; Zhao, R.; Liu, L.; An, Z. Plasma Fingerprint of Free Fatty Acids and Their Correlations with the Traditional Cardiac Biomarkers in Patients with Type 2 Diabetes Complicated by Coronary Heart Disease. Front. Cardiovasc. Med. 2022, 9, 903412. [Google Scholar] [CrossRef]
  41. Khawaja, O.; Bartz, T.M.; Ix, J.H.; Heckbert, S.R.; Kizer, J.R.; Zieman, S.J.; Mukamal, K.J.; Tracy, R.P.; Siscovick, D.S.; Djoussé, L. Plasma Free Fatty Acids and Risk of Atrial Fibrillation (from the Cardiovascular Health Study). Am. J. Cardiol. 2012, 110, 212–216. [Google Scholar] [CrossRef] [PubMed]
  42. Costa, M.D.; Davis, R.B.; Goldberger, A.L. Heart Rate Fragmentation: A New Approach to the Analysis of Cardiac Interbeat Interval Dynamics. Front. Physiol. 2017, 8, 255. [Google Scholar] [CrossRef] [PubMed]
  43. Costa, M.D.; Redline, S.; Davis, R.B.; Heckbert, S.R.; Soliman, E.Z.; Goldberger, A.L. Heart Rate Fragmentation as a Novel Biomarker of Adverse Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Front. Physiol. 2018, 9, 1117. [Google Scholar] [CrossRef]
Figure 1. Significant partial correlations. (A) Correlations considering T2DMG; (B) correlations considering CG. CIHP: complexity index for HP series; HP: heart period; NCIHP: normalized complexity index for HP series; SampEnHP: sample entropy for HP series; SEHP: Shannon’s entropy for HP series; T2DMG: type 2 diabetes mellitus group; VO2PEAK: peak oxygen consumption; W/kgPEAK: relative Watts at peak of exercise. Partial correlations with controls for age, physical activity level, and metabolic cart (the latter only for VO2PEAK in T2DMG, as only in this group were two metabolic carts used), with p < 0.05.
Figure 1. Significant partial correlations. (A) Correlations considering T2DMG; (B) correlations considering CG. CIHP: complexity index for HP series; HP: heart period; NCIHP: normalized complexity index for HP series; SampEnHP: sample entropy for HP series; SEHP: Shannon’s entropy for HP series; T2DMG: type 2 diabetes mellitus group; VO2PEAK: peak oxygen consumption; W/kgPEAK: relative Watts at peak of exercise. Partial correlations with controls for age, physical activity level, and metabolic cart (the latter only for VO2PEAK in T2DMG, as only in this group were two metabolic carts used), with p < 0.05.
Healthcare 14 00940 g001
Figure 2. Correlations between CRC indices and physical and cardiorespiratory fitness variables for the CG and T2DMG groups. Bold coefficient (r) values are significant (p < 0.05). The color intensity is related to the value of the correlation coefficient (red: r = 1; white: r = 0; blue: r = −1). CRC: complexity of cardiovascular regulation; CG: control group; CI: complexity index; HP: heart period; NCI: normalized complexity index; SampEn: sample entropy; SAP: systolic arterial pressure; SE: Shannon’s entropy; T2DMG: type 2 diabetes mellitus group; VO2PEAK: peak oxygen consumption (in mL/kg/min); W/kgPEAK: relative Watts at peak of exercise. Partial correlations with controls for age, physical activity level, and metabolic cart (the latter only for VO2PEAK in T2DMG, as only in this group were two metabolic carts used), with p < 0.05.
Figure 2. Correlations between CRC indices and physical and cardiorespiratory fitness variables for the CG and T2DMG groups. Bold coefficient (r) values are significant (p < 0.05). The color intensity is related to the value of the correlation coefficient (red: r = 1; white: r = 0; blue: r = −1). CRC: complexity of cardiovascular regulation; CG: control group; CI: complexity index; HP: heart period; NCI: normalized complexity index; SampEn: sample entropy; SAP: systolic arterial pressure; SE: Shannon’s entropy; T2DMG: type 2 diabetes mellitus group; VO2PEAK: peak oxygen consumption (in mL/kg/min); W/kgPEAK: relative Watts at peak of exercise. Partial correlations with controls for age, physical activity level, and metabolic cart (the latter only for VO2PEAK in T2DMG, as only in this group were two metabolic carts used), with p < 0.05.
Healthcare 14 00940 g002
Table 1. Anthropometric and clinical characteristics of the subjects studied.
Table 1. Anthropometric and clinical characteristics of the subjects studied.
CharacteristicsT2DMG (n = 34)CG (n = 34)p
Age (years) *58 (53–63)51 (48–56)<0.001
Anthropometric data
     Height (m)1.73 ± 0.061.73 ± 0.070.794
     Body mass (kg) *86.80 (79.65–92.15)73.20 (65.50–83.93)<0.001
     BMI (kg/m2)28.37 ± 3.0525.14 ± 2.82<0.001
Physically active (%) #32.461.80.015
CAN (n, %)
     Early35.3--
     Definitive8.8--
Laboratory exams
     Erythrocytes (million/mm3) *4.84 (4.62–5.23)5.13 (4.95–5.42)0.022
     Hemoglobin (g/dL)14.73 ± 1.4314.81 ± 0.910.770
     Hematocrit (%)42.19 ± 3.7343.56 ± 2.540.391
     Leukocytes (mm3) *6700 (6000–7180)5685 (5103–6865)0.007
     HbA1c (%) (mmol/mol) *7.85 (6.73–9.50)5.20 (5.00–5.50)<0.001
     Basal insulin (mU/mL)12.59 ± 9.206.29 ± 4.30<0.001
     Fasting glucose (mg/dL)173.89 ± 55.7293.68 ± 6.75<0.001
     HOMA-IR 5.23 ± 4.051.45 ± 0.97<0.001
     hs-CRP (mg/L)2.27 ± 1.711.23 ± 1.070.002
     Total cholesterol (mg/dL)181.50 ± 43.05196.79 ± 33.980.109
     HDL-cholesterol (mg/dL)43.32 ± 8.9849.59 ± 11.250.014
     LDL-cholesterol (mg/dL)105.18 ± 31.03124.03 ± 30.310.014
     VLDL-cholesterol (mg/dL)28.85 ± 9.4623.18 ± 14.920.001
     Triglycerides (mg/dL)176.18 ± 91.43117.24 ± 74.60<0.001
Medications
     Hypoglycemic agents (n, %)88.2--
     Antihypertensive agents (n, %)44.1--
     Hypolipidemic agents (n, %)29.4--
Duration of diabetes (years)13 ± 8--
* Data presented as medians and interquartile ranges (Mann–Whitney test). # Physically active: ≥150 min of physical activity per week (comparison evaluated by the chi-square test). Bold values are significant. The BMI, basal insulin, Homa-IR, hs-CRP, VLDL, and triglycerides were analyzed using the transformed data (original data are presented in the table for clarity and interpretation). BMI: body mass index; CAN: cardiovascular autonomic neuropathy; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; HOMA-IR: Homeostasis Model Assessment of Insulin Resistance; hs-CRP: high-sensitivity C-reactive protein; LDL: low-density lipoprotein; VLDL: very-low-density lipoprotein. T-test with p < 0.05.
Table 2. Differences in CRF and physical fitness between the CG and T2DMG.
Table 2. Differences in CRF and physical fitness between the CG and T2DMG.
VariableT2DMG (n = 34)CG (n = 34)pd (95% CI) *
CPET
WPEAK158.56 ± 38.94233.00 ± 60.460.0080.67 (0.18; 1.16)
W/kgPEAK1.89 ± 0.523.15 ± 0.90<0.0011.16 (0.64; 1.68)
VO2PEAK (mL/min)1961.60 ± 481.882543.01 ± 647.87<0.0011.10 (0.58; 1.62)
VO2PEAK (mL/kg/min)23.19 ± 5.6834.24 ± 8.98<0.0011.35 (0.82; 1.88)
HRPEAK (bpm)147.56 ± 17.38160.88 ± 15.170.2430.14 (−0.34; 0.62)
VO2/HR (mL/bpm)13.30 ± 2.9215.82 ± 3.780.0010.81 (0.30; 1.32)
CRC
CIHP1.00 ± 0.181.03 ± 0.160.6110.19 (−0.27; 0.67)
CISAP0.90 ± 0.120.91 ± 0.150.6990.16 (−0.32; 0.64)
NCIHP0.67 ± 0.120.73 ± 0.080.4840.22 (−0.26; 0.70)
NCISAP0.58 ± 0.080.60 ± 0.080.6120.26 (−0.22; 0.74)
SampEnHP1.83 ± 0.362.01 ± 0.240.0780.44 (−0.04; 0.92)
SampEnSAP1.65 ± 0.301.64 ± 0.290.9060.03 (−0.45; 0.51)
SEHP3.45 ± 0.383.43 ± 0.400.1690.35 (−0.13; 0.83)
SESAP3.37 ± 0.273.29 ± 0.350.2270.30 (−0.18; 0.78)
* Calculated based on adjusted mean differences. Bold values are significant. Only the HRPEAK was analyzed using the transformed data (original data are presented in the table for clarity and interpretation). d: Cohen’s d; 95% CI: 95% confidence interval; CG: control group; CIHP: complexity index for HP series; CISAP: complexity index for SAP series; CPET: cardiopulmonary exercise test; CRC: cardiovascular regulation complexity; CRF: cardiorespiratory fitness; HP: heart period; HRPEAK: peak heart rate; NCIHP: normalized complexity index for HP series; NCISAP: normalized complexity index for SAP series; SampEnHP: sample entropy for HP series; SampEnSAP: sample entropy for SAP series; SAP: systolic arterial pressure; SEHP: Shannon’s entropy for HP series; SESAP: Shannon’s entropy for SAP series; T2DMG: type 2 diabetes mellitus group; VO2/HR: oxygen pulse; VO2PEAK: peak oxygen consumption; WPEAK: Watts at peak of exercise; W/kgPEAK: relative Watts at peak of exercise. One-way ANOVA with controls for age, BMI, physical activity level, and metabolic cart (the latter only for VO2 variables), with p < 0.05.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Signini, É.D.F.; de Abreu, R.M.; Castro, A.; Santos, A.M.; Galdino, G.A.M.; Moura, S.C.G.; Linares, S.N.; Milan-Mattos, J.C.; Zambetta, R.M.; Porta, A.; et al. Complexity of Cardiovascular Regulation and Its Association with Physical and Cardiorespiratory Fitness in Men with Type 2 Diabetes Mellitus. Healthcare 2026, 14, 940. https://doi.org/10.3390/healthcare14070940

AMA Style

Signini ÉDF, de Abreu RM, Castro A, Santos AM, Galdino GAM, Moura SCG, Linares SN, Milan-Mattos JC, Zambetta RM, Porta A, et al. Complexity of Cardiovascular Regulation and Its Association with Physical and Cardiorespiratory Fitness in Men with Type 2 Diabetes Mellitus. Healthcare. 2026; 14(7):940. https://doi.org/10.3390/healthcare14070940

Chicago/Turabian Style

Signini, Étore De F., Raphael M. de Abreu, Alex Castro, Andréia M. Santos, Gabriela A. M. Galdino, Silvia C. G. Moura, Stephanie N. Linares, Juliana C. Milan-Mattos, Rafaella M. Zambetta, Alberto Porta, and et al. 2026. "Complexity of Cardiovascular Regulation and Its Association with Physical and Cardiorespiratory Fitness in Men with Type 2 Diabetes Mellitus" Healthcare 14, no. 7: 940. https://doi.org/10.3390/healthcare14070940

APA Style

Signini, É. D. F., de Abreu, R. M., Castro, A., Santos, A. M., Galdino, G. A. M., Moura, S. C. G., Linares, S. N., Milan-Mattos, J. C., Zambetta, R. M., Porta, A., & Catai, A. M. (2026). Complexity of Cardiovascular Regulation and Its Association with Physical and Cardiorespiratory Fitness in Men with Type 2 Diabetes Mellitus. Healthcare, 14(7), 940. https://doi.org/10.3390/healthcare14070940

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop